Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$110.66
At close: Jun 5 EDT
$110.66
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Axsome Therapeutics Analyst Ratings and Price Targets | NASDAQ:AXSM | Benzinga
Axsome Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Axsome Therapeutics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
HC Wainwright & Co.
Wells Fargo
Baird
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Axsome Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/03/2025 | Buy Now | — | Oppenheimer | Matthew Hershenhorn50% | → $185 | Initiates | → Outperform | Get Alert |
| 05/22/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $180 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | — | Wells Fargo | Cerena Chen41% | $160 → $165 | Maintains | Overweight | Get Alert |
| 05/06/2025 | Buy Now | — | Baird | Joel Beatty68% | $160 → $162 | Maintains | Outperform | Get Alert |
| 04/29/2025 | Buy Now | — | RBC Capital | Leonid Timashev38% | $190 → $193 | Maintains | Outperform | Get Alert |
| 04/07/2025 | Buy Now | — | Jefferies | Andrew Tsai25% | → $200 | Initiates | → Buy | Get Alert |
| 04/03/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | — | Needham | Ami Fadia60% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2025 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $212 → $216 | Maintains | Outperform | Get Alert |
| 03/06/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | — | Needham | Ami Fadia60% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | — | Baird | Joel Beatty68% | $132 → $160 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | — | Morgan Stanley | Vikram Purohit38% | $125 → $190 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $195 → $212 | Maintains | Outperform | Get Alert |
| 02/25/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | — | Needham | Ami Fadia60% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | — | Truist Securities | Joon Lee77% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | — | RBC Capital | Leonid Timashev38% | $143 → $192 | Maintains | Outperform | Get Alert |
| 02/19/2025 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $153 → $153 | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | — | Needham | Ami Fadia60% | $133 → $153 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | — | Wells Fargo | Cerena Chen41% | $140 → $160 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | — | Deutsche Bank | David Hoang41% | → $176 | Initiates | → Buy | Get Alert |
| 02/11/2025 | Buy Now | — | B of A Securities | Jason Gerberry69% | $143 → $167 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $137 → $195 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | Buy Now | — | Leerink Partners | Marc Goodman73% | $110 → $150 | Maintains | Outperform | Get Alert |
| 02/10/2025 | Buy Now | — | Needham | Ami Fadia60% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 02/03/2025 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $122 → $137 | Maintains | Outperform | Get Alert |
| 02/03/2025 | Buy Now | — | Truist Securities | Joon Lee77% | $180 → $190 | Maintains | Buy | Get Alert |
| 02/03/2025 | Buy Now | — | RBC Capital | Brian Abrahams50% | $139 → $143 | Maintains | Outperform | Get Alert |
| 01/31/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $190 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | — | RBC Capital | Brian Abrahams50% | $139 → $139 | Maintains | Outperform | Get Alert |
| 01/21/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | — | Needham | Ami Fadia60% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | — | Truist Securities | Joon Lee77% | $150 → $180 | Maintains | Buy | Get Alert |
| 01/06/2025 | Buy Now | — | Needham | Ami Fadia60% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 12/31/2024 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $124 → $122 | Maintains | Outperform | Get Alert |
| 12/31/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | — | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | — | Needham | Ami Fadia60% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $121 → $121 | Reiterates | Overweight → Overweight | Get Alert |
| 11/27/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | — | Baird | Joel Beatty68% | $112 → $116 | Maintains | Outperform | Get Alert |
| 11/13/2024 | Buy Now | — | Needham | Ami Fadia60% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | — | Needham | Ami Fadia60% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2024 | Buy Now | — | RBC Capital | Leonid Timashev38% | $130 → $131 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | — | Needham | Ami Fadia60% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | — | Wells Fargo | Cerena Chen41% | → $140 | Initiates | → Overweight | Get Alert |
| 08/22/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 08/06/2024 | Buy Now | — | UBS | Ashwani Verma49% | $107 → $105 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | — | RBC Capital | Leonid Timashev38% | $131 → $130 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $180 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | — | B of A Securities | Jason Gerberry69% | $95 → $106 | Upgrade | Neutral → Buy | Get Alert |
| 08/06/2024 | Buy Now | — | Needham | Ami Fadia60% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | — | Needham | Ami Fadia60% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | — | RBC Capital | Leonid Timashev38% | $131 → $131 | Reiterates | Outperform → Outperform | Get Alert |
| 07/22/2024 | Buy Now | — | Needham | Ami Fadia60% | → $130 | Initiates | → Buy | Get Alert |
| 07/18/2024 | Buy Now | — | B of A Securities | Jason Gerberry69% | $97 → $95 | Maintains | Neutral | Get Alert |
| 06/12/2024 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $106 → $106 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | — | RBC Capital | Leonid Timashev38% | $127 → $130 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $109 → $106 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | — | Citigroup | David Hoang41% | $127 → $125 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | — | Baird | Joel Beatty68% | $108 → $112 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | — | Morgan Stanley | Vikram Purohit38% | $90 → $115 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 04/02/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $108 → $109 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | — | Truist Securities | Joon Lee77% | → $150 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | — | RBC Capital | Leonid Timashev38% | $123 → $128 | Maintains | Outperform | Get Alert |
| 03/26/2024 | Buy Now | — | Citigroup | David Hoang41% | $125 → $127 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $190 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | — | Baird | Joel Beatty68% | → $108 | Initiates | → Outperform | Get Alert |
| 03/04/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2024 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $112 → $108 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | — | Guggenheim | Yatin Suneja54% | $110 → $125 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | — | RBC Capital | Leonid Timashev38% | $126 → $123 | Maintains | Outperform | Get Alert |
| 02/21/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $108 → $103 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | Buy Now | — | Mizuho | Graig Suvannavejh52% | $90 → $112 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | — | UBS | Ashwani Verma49% | → $111 | Initiates | → Buy | Get Alert |
| 01/25/2024 | Buy Now | — | RBC Capital | Leonid Timashev38% | → $126 | Initiates | → Outperform | Get Alert |
| 01/22/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 01/16/2024 | Buy Now | — | Piper Sandler | David Amsellem73% | $90 → $113 | Maintains | Overweight | Get Alert |
| 12/26/2023 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 12/13/2023 | Buy Now | — | Citigroup | David Hoang41% | → $125 | Initiates | → Buy | Get Alert |
| 12/12/2023 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 09/25/2023 | Buy Now | — | Mizuho | Graig Suvannavejh52% | → $100 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Axsome Therapeutics (AXSM) stock?
The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by Oppenheimer on June 3, 2025. The analyst firm set a price target for $185.00 expecting AXSM to rise to within 12 months (a possible 67.18% upside). 67 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axsome Therapeutics (AXSM)?
The latest analyst rating for Axsome Therapeutics (NASDAQ:AXSM) was provided by Oppenheimer, and Axsome Therapeutics initiated their outperform rating.
When was the last upgrade for Axsome Therapeutics (AXSM)?
The last upgrade for Axsome Therapeutics Inc happened on August 6, 2024 when B of A Securities raised their price target to $106. B of A Securities previously had a neutral for Axsome Therapeutics Inc.
When was the last downgrade for Axsome Therapeutics (AXSM)?
There is no last downgrade for Axsome Therapeutics.
When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on June 3, 2025 so you should expect the next rating to be made available sometime around June 3, 2026.
Is the Analyst Rating Axsome Therapeutics (AXSM) correct?
While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a initiated with a price target of $0.00 to $185.00. The current price Axsome Therapeutics (AXSM) is trading at is $110.66, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
